QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)

Background: Newer therapies, such as dipeptidyl peptidase-IV inhibitors, are increasingly being used in the treatment of type 2 diabetes mellitus (T2DM). Teneligliptin, a DPP4 inhibitor, currently commonly used as monotherapy or as add-on therapy, was generally well tolerated in patients with T2DM d...

Descripción completa

Detalles Bibliográficos
Autores principales: Erande, S, Sarwardekar, S, Desai, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593689/
https://www.ncbi.nlm.nih.gov/pubmed/31417296
http://dx.doi.org/10.2147/DMSO.S202458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593689/
https://www.ncbi.nlm.nih.gov/pubmed/31417296
http://dx.doi.org/10.2147/DMSO.S202458

Ejemplares similares